(E)-methyl 3-(4-ethoxyphenyl)acrylate | 87711-71-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (E)-methyl 3-(4-ethoxyphenyl)acrylate
• 英文别名: methyl (2E)-3-(4-ethoxyphenyl)prop-2-enoate；methyl (E)-3-(4-ethoxyphenyl)prop-2-enoate
• CAS: 87711-71-5
• 化学式: C₁₂H₁₄O₃
• mdl: MFCD09755017
• 分子量: 206.241
• InChiKey: XTZZULGXHUQOEN-RMKNXTFCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)-methyl 3-(4-ethoxyphenyl)acrylate 在 水 、 potassium carbonate 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 作用下， 以 甲醇 、 乙腈 为溶剂， 反应 27.0h， 生成 (E)-3-(4-ethoxystyryl)-[1,2,4]triazolo[3,4-α]phthalazine
  参考文献：
  名称：

  Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents

  摘要：

  Tuberculosis, HIV coinfection with TB, emergence of multidrug-resistant TB, and extensively drug-resistant TB are the major causes of death from infectious diseases worldwide. Because no new drug has been introduced in the last several decades, new classes of molecules as anti-TB drugs are urgently needed. Herein, we report the synthesis and structure-activity relationships of a series of thioester, amide, hydrazide, and triazolophthalazine derivatives of 4-alkoxy cinnamic acid. Many compounds exhibited submicromolar minimum inhibitory concentrations against Mycobacterium tuberculosis strain (H(37)Rv). Interestingly, compound 13e, a 4-isopentenyloxycinnamyl triazolophthalazine derivative, was found to be 100-1800 times more active than isoniazid (INH) when tested for its ability to inhibit the growth of INH-resistant M. tuberculosis strains. The results also revealed that 13e does not interfere with mycolic acid biosynthesis, thereby pointing to a different mode of action and representing an attractive lead compound for the development of new anti-TB agents.

  DOI：

  10.1021/jm101510d
• 作为产物：
  描述：

  4-香豆酸 在 potassium carbonate 、 对甲苯磺酸 作用下， 以 丙酮 为溶剂， 反应 17.0h， 生成 (E)-methyl 3-(4-ethoxyphenyl)acrylate
  参考文献：
  名称：

  水溶性Pd纳米笼对反肉桂酸酯的光二聚化的模板化

  摘要：

  水溶性八面体的Pd纳米笼作为反应容器模板取代的光二反式水-肉桂酸甲基酯。反式的主客体复合物的辐照-肉桂酸甲酯与Pd纳米笼形成了除相应的顺式异构体外还选择性形成顺头二聚体的现象。这些结果表明，客体分子以选择性的方式预取向，其中亲水性酯基面对水而疏水性芳基被塞在主体腔内。这样的取向发生在纳米笼外部和内部之间的疏水-亲水界面处。主体和客体之间的弱分子间CH-π和π-π相互作用可能是反应物烯烃在短的激发态寿命期间缺乏迁移率的原因。

  DOI：

  10.1021/jo0617722

文献信息

• Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application
  申请人：MINNESOTA MINING AND MANUFACTURING COMPANY

  公开号：EP1170275A3

  公开（公告）日：2004-04-14

  Normally liquid, omega-hydrofluoroalkyl ether compounds (and selected mixtures thereof) have a saturated perfluoroaliphatic chain of carbon atoms interrupted by one or more ether oxygen atoms. The compounds can be prepare, e.g. by decarboxylation of the corresponding fluoroalkyl ether carboxylic acids and are useful, e.g., in cleaning and drying applications.

  通常是液体的ω-氢氟烷基醚化合物（及其选定的混合物）具有由一个或多个醚氧原子中断的饱和全氟脂肪链的碳原子。这些化合物可以通过相应的氟烷基醚羧酸的脱羧反应制备，例如在清洁和干燥应用中很有用。
• METHODS OF TREATMENT USING ARYLCYCLOPROPYLAMINE COMPOUNDS
  申请人：Duke University

  公开号：US20130178520A1

  公开（公告）日：2013-07-11

  Described herein are methods of treating Parkinson's disease using arylcyclopropylamine compounds.

  本文描述了使用芳基环丙胺化合物治疗帕金森病的方法。
• Inhibitory Effects of Substituted Cinnamic Acid Esters on Mushroom Tyrosinase
  作者：Zhenghua Zhang、Jinbing Liu、Fengyan Wu、Liangzhong Zhao

  DOI：10.2174/1570180811310060009

  日期：2013.5.1

  A series of substituted cinnamic acid esters were synthesized and their inhibitory effects on the diphenolase activity of mushroom tyrosinase were evaluated. Compound 8 was found to be the most potent inhibitor with IC50 value of 5.60µM. Preliminary structure activity relationships (SARs) were concluded. The inhibition kinetics analyzed by Lineweaver–Burk plots revealed that compound 8 was anti-competitive

  合成了一系列取代的肉桂酸酯，并评价了其对蘑菇酪氨酸酶双酚酶活性的抑制作用。发现化合物8是最有效的抑制剂，IC50值为5.60µM。初步的结构活动关系（SAR）总结。通过Lineweaver-Burk图分析的抑制动力学表明，化合物8是抗竞争性抑制剂。
• ARYLCYCLOPROPYLAMINES AND METHODS OF USE
  申请人：McCafferty Dewey G.

  公开号：US20100324147A1

  公开（公告）日：2010-12-23

  Described herein are arylcyclopropylamine compounds that may inhibit enzymes comprising an amine oxidase domain, such as LSD1, MAO A and/or MAO B.

  本文描述了可能抑制含有胺氧化酶结构域的酶的芳基环丙胺化合物，如LSD1、MAO A和/或MAO B。
• Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
  申请人：Arimilli N. Murty

  公开号：US20070010489A1

  公开（公告）日：2007-01-11

  Phosphonate substituted compounds with HIV protease inhibitory properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit 5 HIV protease activity and/or are useful therapeutically for the treatment of AIDS and other antiviral infections, as well as in assays for the detection of HIV protease.

  本发明揭示了具有HIV蛋白酶抑制剂性质的膦酸酯取代化合物，其具有作为治疗剂和其他工业用途的用途。该组合物抑制5型HIV蛋白酶活性和/或在治疗艾滋病和其他抗病毒感染方面具有治疗作用，以及在检测HIV蛋白酶方面的检测中有用。